HomeZEAL • CPH
add
Zealand Pharma A/S
Nakaraang pagsara
kr 663.00
Sakop ng araw
kr 610.00 - kr 685.00
Sakop ng taon
kr 560.00 - kr 972.00
Market cap
51.95B DKK
Average na Volume
181.53K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 9.06M | -61.02% |
Gastos sa pagpapatakbo | 404.79M | 59.40% |
Net na kita | -291.03M | -9.93% |
Net profit margin | -3.21K | -182.04% |
Kita sa bawat share | -4.12 | 10.43% |
EBITDA | -393.50M | -63.38% |
Aktuwal na % ng binabayarang buwis | 0.20% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 8.23B | 403.72% |
Kabuuang asset | 9.51B | 380.08% |
Kabuuang sagutin | 888.86M | 129.59% |
Kabuuang equity | 8.62B | — |
Natitirang share | 70.65M | — |
Presyo para makapag-book | 5.44 | — |
Return on assets | -10.35% | — |
Return on capital | -10.83% | — |
Cash Flow
Net change in cash
| (DKK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -291.03M | -9.93% |
Cash mula sa mga operasyon | -180.48M | -403.25% |
Cash mula sa pag-invest | 150.75M | 2,150.61% |
Cash mula sa financing | -4.60M | -182.26% |
Net change in cash | -30.72M | -147.35% |
Malayang cash flow | -117.23M | -199.32% |
Tungkol
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Itinatag
Abr 1, 1997
Website
Mga Empleyado
335
